Zhilin Li is CEO & Interim CFO of CHINA PHARMA HOLDINGS, INC.. Currently has a direct ownership of 15.1 Million shares of CPHI, which is worth approximately $3.18 Million. The most recent transaction as insider was on Sep 29, 2023, when has been sold 13,757,063 shares (Common Stock) at a price of $0.14 per share, resulting in proceeds of $1,925,988. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.1M
0% 3M change
0% 12M change
Total Value Held $3.18 Million

Zhilin Li Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 29 2023
BUY
Grant, award, or other acquisition
$1,925,988 $0.14 p/Share
13,757,063 Added 47.61%
15,138,063 Common Stock
Sep 09 2021
BUY
Grant, award, or other acquisition
$1,179,200 $0.67 p/Share
1,760,000 Added 11.3%
13,810,000 Common Stock
Dec 23 2020
BUY
Grant, award, or other acquisition
-
2,000,000 Added 14.23%
12,050,000 Common Stock
ZL

Zhilin Li

CEO & Interim CFO
Haikou, F4

Track Institutional and Insider Activities on CPHI

Follow CHINA PHARMA HOLDINGS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPHI shares.

Notify only if

Insider Trading

Get notified when an China Pharma Holdings, Inc. insider buys or sells CPHI shares.

Notify only if

News

Receive news related to CHINA PHARMA HOLDINGS, INC.

Track Activities on CPHI